ETS1 and gastric neoplasm: The expression difference of the reporter gene suggests that the CRISPReader system can effectively distinguish gastric tumor cells from normal gastric cells, indicating that the Ets-1-sensing CRISPReader system has potential broad-spectrum anti-tumor capabilities.